First Time Loading...
I

InterCure Ltd
TASE:INCR

Watchlist Manager
InterCure Ltd
TASE:INCR
Watchlist
Price: 1 228 ILS -1.13% Market Closed
Updated: May 10, 2024

Intrinsic Value

INCR's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

InterCure Ltd. engages in the business of medical cannabis and biomedicine. [ Read More ]

The intrinsic value of one INCR stock under the Base Case scenario is 1 358.42 ILS. Compared to the current market price of 1 228 ILS, InterCure Ltd is Undervalued by 10%.

Key Points:
INCR Intrinsic Value
Base Case
1 358.42 ILS
Undervaluation 10%
Intrinsic Value
Price
I
Worst Case
Base Case
Best Case

Valuation Backtest
InterCure Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling INCR stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
InterCure Ltd

Provide an overview of the primary business activities
of InterCure Ltd.

What unique competitive advantages
does InterCure Ltd hold over its rivals?

What risks and challenges
does InterCure Ltd face in the near future?

Summarize the latest earnings call
of InterCure Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for InterCure Ltd.

Provide P/S
for InterCure Ltd.

Provide P/E
for InterCure Ltd.

Provide P/OCF
for InterCure Ltd.

Provide P/FCFE
for InterCure Ltd.

Provide P/B
for InterCure Ltd.

Provide EV/S
for InterCure Ltd.

Provide EV/GP
for InterCure Ltd.

Provide EV/EBITDA
for InterCure Ltd.

Provide EV/EBIT
for InterCure Ltd.

Provide EV/OCF
for InterCure Ltd.

Provide EV/FCFF
for InterCure Ltd.

Provide EV/IC
for InterCure Ltd.

Show me price targets
for InterCure Ltd made by professional analysts.

What are the Revenue projections
for InterCure Ltd?

How accurate were the past Revenue estimates
for InterCure Ltd?

What are the Net Income projections
for InterCure Ltd?

How accurate were the past Net Income estimates
for InterCure Ltd?

What are the EPS projections
for InterCure Ltd?

How accurate were the past EPS estimates
for InterCure Ltd?

What are the EBIT projections
for InterCure Ltd?

How accurate were the past EBIT estimates
for InterCure Ltd?

Compare the revenue forecasts
for InterCure Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of InterCure Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of InterCure Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of InterCure Ltd compared to its peers.

Compare the P/E ratios
of InterCure Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing InterCure Ltd with its peers.

Analyze the financial leverage
of InterCure Ltd compared to its main competitors.

Show all profitability ratios
for InterCure Ltd.

Provide ROE
for InterCure Ltd.

Provide ROA
for InterCure Ltd.

Provide ROIC
for InterCure Ltd.

Provide ROCE
for InterCure Ltd.

Provide Gross Margin
for InterCure Ltd.

Provide Operating Margin
for InterCure Ltd.

Provide Net Margin
for InterCure Ltd.

Provide FCF Margin
for InterCure Ltd.

Show all solvency ratios
for InterCure Ltd.

Provide D/E Ratio
for InterCure Ltd.

Provide D/A Ratio
for InterCure Ltd.

Provide Interest Coverage Ratio
for InterCure Ltd.

Provide Altman Z-Score Ratio
for InterCure Ltd.

Provide Quick Ratio
for InterCure Ltd.

Provide Current Ratio
for InterCure Ltd.

Provide Cash Ratio
for InterCure Ltd.

What is the historical Revenue growth
over the last 5 years for InterCure Ltd?

What is the historical Net Income growth
over the last 5 years for InterCure Ltd?

What is the current Free Cash Flow
of InterCure Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for InterCure Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
InterCure Ltd

Current Assets 394.5m
Cash & Short-Term Investments 102.8m
Receivables 134.4m
Other Current Assets 157.3m
Non-Current Assets 447.3m
Long-Term Investments 42.6m
PP&E 97m
Intangibles 284.2m
Other Non-Current Assets 23.6m
Current Liabilities 207.8m
Accounts Payable 144.1m
Short-Term Debt 957k
Other Current Liabilities 62.7m
Non-Current Liabilities 125.3m
Long-Term Debt 105.4m
Other Non-Current Liabilities 20m
Efficiency

Earnings Waterfall
InterCure Ltd

Revenue
414.8m ILS
Cost of Revenue
-265.3m ILS
Gross Profit
149.5m ILS
Operating Expenses
-109.5m ILS
Operating Income
40m ILS
Other Expenses
-19.1m ILS
Net Income
20.9m ILS

Free Cash Flow Analysis
InterCure Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

INCR Profitability Score
Profitability Due Diligence

InterCure Ltd's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
ROIC is Increasing
Positive ROIC
45/100
Profitability
Score

InterCure Ltd's profitability score is 45/100. The higher the profitability score, the more profitable the company is.

INCR Solvency Score
Solvency Due Diligence

InterCure Ltd's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
46/100
Solvency
Score

InterCure Ltd's solvency score is 46/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

INCR Price Targets Summary
InterCure Ltd

There are no price targets for INCR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

INCR Price
InterCure Ltd

1M 1M
+30%
6M 6M
+197%
1Y 1Y
+42%
3Y 3Y
-47%
5Y 5Y
-72%
10Y 10Y
+556%
Annual Price Range
1 228
52w Low
395
52w High
1 254
Price Metrics
Average Annual Return -20.38%
Standard Deviation of Annual Returns 36.53%
Max Drawdown -91%
Shares Statistics
Market Capitalization 590.5m ILS
Shares Outstanding 480 884
Percentage of Shares Shorted
N/A

INCR Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

InterCure Ltd

Country

Israel

Industry

Pharmaceuticals

Market Cap

590.5m ILS

Dividend Yield

0%

Description

InterCure Ltd. engages in the business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

Contact

Herzliya
Medinat HaYehudim 85
+972774605012.0
https://www.intercure.co/

IPO

2007-07-26

Employees

75

Officers

CEO & Director
Mr. Alexander Rabinovich
Chief Financial Officer
Mr. Amos Cohen
Vice President of Sales
Einat Zehavi
Corporate Controller
Mr. Omri Batzir

See Also

Discover More
What is the Intrinsic Value of one INCR stock?

The intrinsic value of one INCR stock under the Base Case scenario is 1 358.42 ILS.

Is INCR stock undervalued or overvalued?

Compared to the current market price of 1 228 ILS, InterCure Ltd is Undervalued by 10%.